<?xml version="1.0" ?>
<document id="1297127819be12e7f5319edd0a9b35fd5cc566b7">
  <chunk id="1297127819be12e7f5319edd0a9b35fd5cc566b7.c0" text="An RNA Aptamer Provides a Novel Approach for the Induction of Apoptosis by Targeting the HPV16 E7 Oncoprotein"/>
  <chunk id="1297127819be12e7f5319edd0a9b35fd5cc566b7.c1" text="Background: Human papillomavirus 16 (HPV16) is a high-risk DNA tumour virus, which is a major causative agent of cervical cancer. Cellular transformation is associated with deregulated expression of the E6 and E7 oncogenes. E7 has been shown to bind a number of cellular proteins, including the cell cycle control protein pRb. In this study, RNA aptamers (small, singlestranded oligonucleotides selected for high-affinity binding) to HPV16 E7 were employed as molecular tools to further investigate these protein-protein interactions.">
    <entity charOffset="63-69" id="1297127819be12e7f5319edd0a9b35fd5cc566b7.c1.e0" ontology_id="HP_0002664" text="tumour" type="phenotype"/>
    <entity charOffset="295-305" id="1297127819be12e7f5319edd0a9b35fd5cc566b7.c1.e1" ontology_id="GO_0007049" text="cell cycle" type="gene_function"/>
    <entity charOffset="295-313" id="1297127819be12e7f5319edd0a9b35fd5cc566b7.c1.e2" ontology_id="GO_1901987" text="cell cycle control" type="gene_function"/>
    <entity charOffset="422-429" id="1297127819be12e7f5319edd0a9b35fd5cc566b7.c1.e3" ontology_id="GO_0005488" text="binding" type="gene_function"/>
    <pair e1="1297127819be12e7f5319edd0a9b35fd5cc566b7.c1.e0" e2="1297127819be12e7f5319edd0a9b35fd5cc566b7.c1.e1" id="1297127819be12e7f5319edd0a9b35fd5cc566b7.c1.p0" relation="true"/>
    <pair e1="1297127819be12e7f5319edd0a9b35fd5cc566b7.c1.e0" e2="1297127819be12e7f5319edd0a9b35fd5cc566b7.c1.e2" id="1297127819be12e7f5319edd0a9b35fd5cc566b7.c1.p1" relation="true"/>
    <pair e1="1297127819be12e7f5319edd0a9b35fd5cc566b7.c1.e0" e2="1297127819be12e7f5319edd0a9b35fd5cc566b7.c1.e3" id="1297127819be12e7f5319edd0a9b35fd5cc566b7.c1.p2" relation="true"/>
  </chunk>
  <chunk id="1297127819be12e7f5319edd0a9b35fd5cc566b7.c2" text="This study is focused on one aptamer (termed A2). Transfection of this molecule into HPV16-transformed cells resulted in inhibition of cell proliferation (shown using real-time cell electronic sensing and MTT assays) due to the induction of apoptosis (as demonstrated by Annexin V/propidium iodide staining). GST-pull down and bead binding assays were used to demonstrate that the binding of A2 required N-terminal residues of E7 known to be involved in interaction with the cell cycle control protein, pRb. Using a similar approach, A2 was shown to disrupt the interaction between E7 and pRb in vitro. Furthermore, transfection of HPV16-transformed cells with A2 appeared to result in the loss of E7 and rise in pRb levels, as observed by immunoblotting.">
    <entity charOffset="135-153" id="1297127819be12e7f5319edd0a9b35fd5cc566b7.c2.e0" ontology_id="GO_0008283" text="cell proliferation" type="gene_function"/>
    <entity charOffset="332-339" id="1297127819be12e7f5319edd0a9b35fd5cc566b7.c2.e1" ontology_id="GO_0005488" text="binding" type="gene_function"/>
    <entity charOffset="381-388" id="1297127819be12e7f5319edd0a9b35fd5cc566b7.c2.e2" ontology_id="GO_0005488" text="binding" type="gene_function"/>
    <entity charOffset="475-485" id="1297127819be12e7f5319edd0a9b35fd5cc566b7.c2.e3" ontology_id="GO_0007049" text="cell cycle" type="gene_function"/>
    <entity charOffset="475-493" id="1297127819be12e7f5319edd0a9b35fd5cc566b7.c2.e4" ontology_id="GO_1901987" text="cell cycle control" type="gene_function"/>
  </chunk>
  <chunk id="1297127819be12e7f5319edd0a9b35fd5cc566b7.c3" text="Conclusions/Significance: This paper includes the first characterisation of the effects of an E7 RNA aptamer in a cell line derived from a cervical carcinoma. Transfection of cells with A2 was correlated with the loss of E7 and the induction of apoptosis. Aptamers specific for a number of cellular and viral proteins have been documented previously; one aptamer (Macugen) is approved for clinical use and several others are in clinical trials. In addition to its role as a molecular tool, A2 could have further applications in the future."/>
</document>
